Amboy Street Ventures invests $1m in Aunt Flow

Amboy Street Ventures (ASV) is excited to announce its latest $1m investment in Aunt Flow to support the company’s plans to make free, 100% organic cotton period products available in every restroom, changing the world one cycle at a time.

Aunt Flow is committed to ensuring everyone has access to menstrual products by placing free menstrual products in public and corporate bathrooms. It already has placed patented free-vend innovative dispensers with 100% organic cotton period products in 23,000 bathrooms, with partners including Netflix and Google’s offices; Princeton and Penn State University, among others; and is in more than 200 Apple retail stores.

With the funding, Aunt Flow will be able to expand its customer base nationally, grow advocacy efforts, donate more than a million products to grassroots partners and introduce new products and more sustainable packaging.

Claire Coder, Chief Estrogen Officer (CEO) of Aunt Flow, said, “How people think about periods is changing. We are proud to be at the forefront of the menstrual movement, with a singular focus on making period products accessible to everyone. If toilet paper is offered for free in public restrooms, tampons and pads should be too.”

Carli Sapir, Founding Partner of Amboy Street Ventures, said, “It’s time to improve the quality and accessibility of menstrual products. It is a pleasure to see brands like Aunt Flow make sustainable, high quality menstrual products ubiquitous. While the D2C menstrual product space is crowded, Aunt Flow has a unique B2B strategy which allows it to break through the crowd. Not only is innovation in this space a huge economic opportunity, it is also creating much needed progress in the underserved women’s health space.”

Aunt Flow is the latest brand to join ASV’s growing portfolio of brands at the forefront of social change in the industry including Contraline, a medical device company devoted to providing men and couples with long-lasting, safe and effective male contraception; Dipsea, an audio erotica platform where sexual wellness meets storytelling; Gennev, the digital health platform for women in menopause and Dame Products, a leading female-focused sexual wellness brand.

Continue Reading

Top 10 Deals of 2026: ŌURA to Acquire Counsel Health for $625M

Every year, Amboy Street highlights the top 10 transactions in women’s health. The next deal in this year’s series is ŌURA’s agreement to acquire Counsel Health, an AI-native primary care company, for $625 million in cash.

Top 10 Deals of 2026: Ferring to Acquire Gameto for up to $1.38B

Every year, Amboy Street highlights the top 10 transactions in women’s health. The splashy news of the week, and the next blog in our series, is Ferring Pharmaceuticals’ agreement to acquire Gameto, a cell-engineering company reimagining IVF, in a deal worth up to $1.38 billion.

Top 10 Deals of 2026: Sun Pharma to Acquire Organon for $11.75B

Every year, Amboy Street highlights the top 10 transactions in women’s health. This year’s series starts with one of the largest women’s health mergers in history.

Top 10 Deals of 2026: ŌURA to Acquire Counsel Health for $625M

Every year, Amboy Street highlights the top 10 transactions in women’s health. The next deal in this year’s series is ŌURA’s agreement to acquire Counsel Health, an AI-native primary care company, for $625 million in cash.

Top 10 Deals of 2026: Ferring to Acquire Gameto for up to $1.38B

Every year, Amboy Street highlights the top 10 transactions in women’s health. The splashy news of the week, and the next blog in our series, is Ferring Pharmaceuticals’ agreement to acquire Gameto, a cell-engineering company reimagining IVF, in a deal worth up to $1.38 billion.

Fast track our industry.
Get in touch today.